Varex Imaging Corporation (VREX): Price and Financial Metrics

Varex Imaging Corporation (VREX)

Today's Latest Price: $16.50 USD

0.18 (-1.08%)

Updated Dec 1 4:00pm

Add VREX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

VREX Stock Summary

  • Varex Imaging Corp's stock had its IPO on January 30, 2017, making it an older stock than merely 13.45% of US equities in our set.
  • Price to trailing twelve month operating cash flow for VREX is currently 49, higher than 91.65% of US stocks with positive operating cash flow.
  • Over the past twelve months, VREX has reported earnings growth of -175.33%, putting it ahead of just 11.3% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Varex Imaging Corp are VSTM, SCOR, PAR, MDRX, and ITRI.
  • VREX's SEC filings can be seen here. And to visit Varex Imaging Corp's official web site, go to

VREX Stock Price Chart Interactive Chart >

Price chart for VREX

VREX Price/Volume Stats

Current price $16.50 52-week high $32.21
Prev. close $16.68 52-week low $10.36
Day low $16.46 Volume 502,000
Day high $17.09 Avg. volume 434,117
50-day MA $13.89 Dividend yield N/A
200-day MA $17.08 Market Cap 645.15M

Varex Imaging Corporation (VREX) Company Bio

Varex Imaging Corporation. spun off from Varian Medical Systems, is focused on being a high-volume manufacturer of X-ray tubes, flat panel detectors and high-voltage connectors as well as a supplier of imaging software and specialized accelerators for high-energy x-ray imaging.

VREX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$16.50$0.78 -95%

We started the process of determining a valid price forecast for Varex Imaging Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Varex Imaging Corp ranked in the 7th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 95%. As for the metrics that stood out in our discounted cash flow analysis of Varex Imaging Corp, consider:

  • The company's compound free cash flow growth rate over the past 4.01 years comes in at -0.19%; that's greater than only 8.52% of US stocks we're applying DCF forecasting to.
  • The company has produced more trailing twelve month cash flow than merely 19.42% of its sector Healthcare.
  • Varex Imaging Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.18. This coverage rate is greater than that of merely 24.88% of stocks we're observing for the purpose of forecasting via discounted cash flows.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as VREX, try LUMO, NVST, OSMT, COO, and EW.

VREX Latest News Stream

Event/Time News Detail
Loading, please wait...

VREX Latest Social Stream

Loading social stream, please wait...

View Full VREX Social Stream

Latest VREX News From Around the Web

Below are the latest news stories about Varex Imaging Corp that investors may wish to consider to help them evaluate VREX as an investment opportunity.

Varex announces $300M senior secured notes offering

Varex Imaging (VREX) commenced a $300M private offering of senior secured notes due 2027. Proceeds will be used to pay in full all amounts outstanding under its existing credit facility, which includes its term loan and revolving credit facility, and for general corporate purposes.Concurrent with the proposed Offering, the company...

Seeking Alpha | September 22, 2020

Varex Announces Private Offering of $300 Million of Senior Secured Notes

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has commenced a private offering (the “Offering”), subject to market and other conditions, of $300 million aggregate principal amount of senior secured notes due 2027 (the “notes”). Varex intends to use the net proceeds from the sale of the notes to pay in full all amounts outstanding under its existing credit facility, which includes its term loan and revolving credit facility, and for general corporat

Business Wire | September 22, 2020

Varex Names Timothy E. Guertin to Board of Directors

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that Timothy E. Guertin has been appointed to the company’s Board of Directors, effective September 2, 2020. Mr. Guertin is a member of the Board of Directors at Teradyne Inc., a maker of automated test equipment and industrial robotics, and Chair of the Global Access to Cancer Care foundation, which works to expand the availability of modern cancer care in developing countries. He is the former Chief Exec

Business Wire | September 3, 2020

IPO Update: Nano-X Imaging Seeks $100 Million U.S. IPO

Quick Take Nano-X Imaging (NNOX) intends to raise $100 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is developing an improved and less costly form of medical imaging technology. NNOX is preparing to go to market with multiple revenue...

Donovan Jones on Seeking Alpha | August 17, 2020

Mid-Day Market Update: Nasdaq Surges 100 Points; Varex Imaging Shares Plummet

Midway through trading Thursday, the Dow traded down 0.13% to 27939.90 while the NASDAQ rose 0.91% to 11,113. The S&P also rose, gaining 0.13% to …

Benzinga | August 13, 2020

Read More 'VREX' Stories Here

VREX Price Returns

1-mo 21.15%
3-mo 50.00%
6-mo -6.67%
1-year -43.71%
3-year -55.55%
5-year N/A
YTD -44.65%
2019 25.89%
2018 -41.05%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8313 seconds.